Hernandez, Carolina Dagli; Ferreira, Glaucio Monteiro 
; Freitas, Renata Caroline Costa de ; Borges, Jéssica Bassani ; Oliveira, Victor Fernandes de; Gonçalves, Rodrigo Marques; Faludi, Andre Arpad; Marçal, Elisangela da Silva Rodrigues; Bastos, Gisele Medeiros ; Bortolin, Raul Hernandes ; Hirata, Mario Hiroyuki ; Hirata, Rosario Dominguez Crespo
Source: Pharmacogenetics and Genomics. Unidades: FCF, IDPC
Subjects: HIPERCOLESTEROLEMIA, ESTATINAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HERNANDEZ, Carolina Dagli et al. Predicted deleterious variants in ABCA1, LPL, LPA and KIF6 are associated with statin response and adverse events in patients with familial hypercholesterolemia and disturb protein structure and stability. Pharmacogenetics and Genomics, v. 34, n. 4, p. 91-104, 2024Tradução . . Disponível em: https://dx.doi.org/10.1097/FPC.0000000000000524. Acesso em: 04 jul. 2024.APA
Hernandez, C. D., Ferreira, G. M., Freitas, R. C. C. de, Borges, J. B., Oliveira, V. F. de, Gonçalves, R. M., et al. (2024). Predicted deleterious variants in ABCA1, LPL, LPA and KIF6 are associated with statin response and adverse events in patients with familial hypercholesterolemia and disturb protein structure and stability. Pharmacogenetics and Genomics, 34( 4), 91-104. doi:10.1097/FPC.0000000000000524NLM
Hernandez CD, Ferreira GM, Freitas RCC de, Borges JB, Oliveira VF de, Gonçalves RM, Faludi AA, Marçal E da SR, Bastos GM, Bortolin RH, Hirata MH, Hirata RDC. Predicted deleterious variants in ABCA1, LPL, LPA and KIF6 are associated with statin response and adverse events in patients with familial hypercholesterolemia and disturb protein structure and stability [Internet]. Pharmacogenetics and Genomics. 2024 ; 34( 4): 91-104.[citado 2024 jul. 04 ] Available from: https://dx.doi.org/10.1097/FPC.0000000000000524Vancouver
Hernandez CD, Ferreira GM, Freitas RCC de, Borges JB, Oliveira VF de, Gonçalves RM, Faludi AA, Marçal E da SR, Bastos GM, Bortolin RH, Hirata MH, Hirata RDC. Predicted deleterious variants in ABCA1, LPL, LPA and KIF6 are associated with statin response and adverse events in patients with familial hypercholesterolemia and disturb protein structure and stability [Internet]. Pharmacogenetics and Genomics. 2024 ; 34( 4): 91-104.[citado 2024 jul. 04 ] Available from: https://dx.doi.org/10.1097/FPC.0000000000000524
